Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.

A van der Burgh, J Dees, W C Hop, M van Blankenstein

Department of Internal Medicine II, University Hospital Rotterdam, Netherlands.

BACKGROUND: Barrett's oesophagus carries a 30-fold to 40-fold increased risk of oesophageal cancer. It is unknown whether endoscopic surveillance programmes reduce mortality from oesophageal cancer. METHODS: A cohort study was undertaken of all 166 patients in whom the diagnosis Barrett's oesophagus had been established between 1973 and 1986. RESULTS: One hundred and fifty five of 166 patients could be traced (93%). During a mean follow up of 9.3 years (amounting to 1440 patient years) eight patients had developed oesophageal cancer at random intervals (one case in 180 patient years). All but one of the tumours were diagnosed at endoscopy for symptoms, three in the stage of carcinoma in situ. Risk factors for the development of oesophageal cancer were extensive Barrett's oesophagus exceeding 10 cm (p = 0.02) and Barrett's ulcer at the time of intake (p = 0.009). Seventy six patients were alive; three had undergone surgery for oesophageal cancer and were without recurrence respectively, 12.8 years, 12.1 years, and 7 months postoperatively. Seventy nine patients had died; five of them had developed oesophageal cancer, but in only two cases this had been the cause of death (2.5%). CONCLUSIONS: Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. The patients of this cohort would not have benefited from an endoscopic surveillance programme.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Li, X., Galipeau, P. C., Sanchez, C. A., Blount, P. L., Maley, C. C., Arnaudo, J., Peiffer, D. A., Pokholok, D., Gunderson, K. L., Reid, B. J. (2008). Single Nucleotide Polymorphism-Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression. Cancer Prevention Research 1: 413-423 [Abstract] [Full Text]  
• Kahrilas, P. J. (2008). Gastroesophageal Reflux Disease. NEJM 359: 1700-1707 [Full Text]  
• Yousef, F., Cardwell, C., Cantwell, M. M., Galway, K., Johnston, B. T., Murray, L. (2008). The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis. Am J Epidemiol 168: 237-249 [Abstract] [Full Text]  
• Siahpush, S. H., Vaughan, T. L., Lampe, J. N., Freeman, R., Lewis, S., Odze, R. D., Blount, P. L., Ayub, K., Rabinovitch, P. S., Reid, B. J., Chen, C. (2007). Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev. 16: 2387-2395 [Abstract] [Full Text]  
• Cook, M. B., Wild, C. P., Everett, S. M., Hardie, L. J., Bani-Hani, K. E., Martin, I. G., Forman, D. (2007). Risk of Mortality and Cancer Incidence in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev. 16: 2090-2096 [Abstract] [Full Text]  
• Brankley, S. M., Wang, K. K., Harwood, A. R., Miller, D. V., Legator, M. S., Lutzke, L. S., Kipp, B. R., Morrison, L. E., Halling, K. C. (2006). The Development of a Fluorescence in Situ Hybridization Assay for the Detection of Dysplasia and Adenocarcinoma in Barrett's Esophagus. J. Mol. Diagn. 8: 260-267 [Abstract] [Full Text]  
• Wongsurawat, V. J., Finley, J. C., Galipeau, P. C., Sanchez, C. A., Maley, C. C., Li, X., Blount, P. L., Odze, R. D., Rabinovitch, P. S., Reid, B. J. (2006). Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation.. Cancer Epidemiol. Biomarkers Prev. 15: 509-516 [Abstract] [Full Text]  
• Cook, M. B., Wild, C. P., Forman, D. (2005). A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett's Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease. Am J Epidemiol 162: 1050-1061 [Abstract] [Full Text]  
• Dellon, E. S., Shaheen, N. J. (2005). Does Screening for Barrett's Esophagus and Adenocarcinoma of the Esophagus Prolong Survival?. JCO 23: 4478-4482 [Abstract] [Full Text]  
• Sharma, P, Sidorenko, E I (2005). Are screening and surveillance for Barrett's oesophagus really worthwhile?. Gut 54: i27-i32 [Abstract] [Full Text]  
• Solaymani-Dodaran, M, Logan, R F A, West, J, Card, T, Coupland, C (2004). Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 53: 1070-1074 [Abstract] [Full Text]  
• Chang, J. T., Katzka, D. A. (2004). Gastroesophageal Reflux Disease, Barrett Esophagus, and Esophageal Adenocarcinoma. Arch Intern Med 164: 1482-1488 [Abstract] [Full Text]  
• Heading, R C (2003). Barrett's oesophagus: epidemiology comes up with a surprise. Gut 52: 1079-1080 [Full Text]  
• Anderson, L A, Murray, L J, Murphy, S J, Fitzpatrick, D A, Johnston, B T, Watson, R G P, McCarron, P, Gavin, A T (2003). Mortality in Barrett's oesophagus: results from a population based study. Gut 52: 1081-1084 [Abstract] [Full Text]  
• Doak, S H, Jenkins, G J S, Parry, E M, D'Souza, F R, Griffiths, A P, Toffazal, N, Shah, V, Baxter, J N, Parry, J M (2003). Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Gut 52: 623-628 [Abstract] [Full Text]  
• Arents, N L A, Thijs, J C, Kleibeuker, J H (2002). A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgrad. Med. J. 78: 707-716 [Abstract] [Full Text]  
• Playford, R J (2002). Endoscopic surveillance of patients with Barrett's oesophagus. Gut 51: 314-315 [Full Text]  
• Vaughan, T. L., Kristal, A. R., Blount, P. L., Levine, D. S., Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Rabinovitch, P. S., Reid, B. J. (2002). Nonsteroidal Anti-inflammatory Drug Use, Body Mass Index, and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev. 11: 745-752 [Abstract] [Full Text]  
• Basu, K K, de Caestecker, J S (2002). Surveillance in Barrett's oesophagus: a personal view. Postgrad. Med. J. 78: 263-268 [Abstract] [Full Text]  
• Shaheen, N., Ransohoff, D. F. (2002). Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review. JAMA 287: 1972-1981 [Abstract] [Full Text]  
• Conio, M, Cameron, A J, Romero, Y, Branch, C D, Schleck, C D, Burgart, L J, Zinsmeister, A R, Melton, L J III, Locke, G R III (2001). Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48: 304-309 [Abstract] [Full Text]  
• McGarrity, T. J (2000). Barrett's oesophagus: the continuing conundrum. BMJ 321: 1238-1239 [Full Text]  
• Rudolph, R. E., Vaughan, T. L., Storer, B. E., Haggitt, R. C., Rabinovitch, P. S., Levine, D. S., Reid, B. J. (2000). Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus. ANN INTERN MED 132: 612-620 [Abstract] [Full Text]  
• Walch, A. K., Zitzelsberger, H. F., Bruch, J., Keller, G., Angermeier, D., Aubele, M. M., Mueller, J., Stein, H., Braselmann, H., Siewert, J. R., Hofler, H., Werner, M. (2000). Chromosomal Imbalances in Barrett’s Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence. Am. J. Pathol. 156: 555-566 [Abstract] [Full Text]  
• Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G. M., Reid, B. J. (1999). Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue. JNCI J Natl Cancer Inst 91: 2087-2095 [Abstract] [Full Text]  
• van Sandick, J W, van Lanschot, J J B, Kuiken, B W, Tytgat, G N J, Offerhaus, G J A, Obertop, H (1998). Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43: 216-222 [Abstract] [Full Text]  
• FITZGERALD, R C, BURNHAM, W R, MACDONALD, C E, WICKS, A C, PLAYFORD, R J (1998). Consideration of histopathological subtypes and biopsy techniques in Barrett's oesophagus surveillance programmes • Reply. Gut 42: 448a-448 [Full Text]  
• Barbezat, G O (1998). Recent advances: Gastroenterology. BMJ 316: 125-128 [Full Text]  
• Macdonald, C E, Wicks, A C, Playford, R J (1997). Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital. Gut 41: 303-307 [Abstract] [Full Text]